Rhodiola Rosea

Rhodiola rosea is an adaptogenic herb native to cold, high-altitude environments in Europe and Asia. It has been used in traditional medicine in Scandinavia, Russia, and Eastern Europe for centuries to enhance physical and mental endurance. Clinical evidence supports its use for stress-related fatigue, mental performance under pressure, and exercise endurance — making it one of the most practically validated adaptogens.

Rosavins and salidroside (the primary bioactive compounds) modulate the stress response through HPA axis regulation and catecholamine activity. Rhodiola appears to preserve serotonin and dopamine levels under stress, inhibit monoamine oxidase (MAO-A and MAO-B), and protect mitochondrial function through antioxidant mechanisms. Clinical trials consistently demonstrate reduced perceived fatigue and improved cognitive function under stress conditions.

200–600 mg standardized extract/day. Most research uses 200–400 mg/day of an extract standardized to ≥3% rosavins and ≥1% salidroside. Taken in the morning or before stressful events — stimulating effects may interfere with sleep if taken late. Often cycled (5 days on, 2 days off).

Standardized extract (≥3% rosavins, ≥1% salidroside): Matches clinical research specifications; ensures consistent rosavin and salidroside content | SHR-5 extract: The specific branded extract used in most European clinical trials | Non-standardized root powder: Active compound content unverified; clinical effect unreliable

Generally very well tolerated. May cause mild agitation or insomnia if taken in the evening. Weak MAO-inhibiting activity — caution with antidepressants, particularly SSRIs and MAOIs (consult physician). Avoid during pregnancy. This information is educational and is not medical advice.

SuppsBuddy requires rosavin and salidroside standardization percentages. Products meeting the ≥3%/≥1% threshold receive full ingredient quality scores. Unstandardized powders are flagged as unreliable.